Red meat consumption and cancer: Reasons to suspect involvement of bovine infectious factors in colorectal cancer
International Journal of Cancer,

zur Hausen H et al. – The available data are compatible with the interpretation that a specific beef factor, suspected to be one or more thermo–resistant potentially oncogenic bovine viruses (e.g. polyoma–, papilloma–, or possibly single–stranded DNA viruses) may contaminate beef preparations and lead to latent infections in the colorectal tract. Preceding, concomitant or subsequent exposure to chemical carcinogens arising during cooking procedures should result in increased risk for colorectal cancer synergistic with these infections.

Please login or register to follow this author.
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Oncology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

<

Most Popular Oncology Articles

1 Metformin for primary colorectal cancer prevention in patients with diabetes: A case-control study in a US population Cancer, December 3, 2014    Clinical Article

2 Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: A pooled analysis of individual patient data from four randomised controlled trials The Lancet Oncology, December 2, 2014    Clinical Article

3 Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: A pooled analysis of individual patient data from four randomised controlled trials The Lancet Oncology, November 26, 2014    Clinical Article

4 Targeted therapies in metastatic colorectal cancer: A systematic review and assessment of currently available data Full Text The Oncologist, November 6, 2014    Free full text    Review Article

5 Does the primary site of colorectal cancer impact outcomes for patients with metastatic disease? Cancer, November 24, 2014    Clinical Article
Exclusive Author Commentary

6 Local resection compared with radical resection in the treatment of T1N0M0 rectal adenocarcinoma: A systematic review and meta-analysis Diseases of the Colon and Rectum, December 12, 2014    Evidence Based Medicine    Review Article

7 Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of wild-type KRAS metastatic colorectal cancer: Final results of a phase II, open-label, clinical trial Full Text BMC Cancer, December 10, 2014    Free full text    Clinical Article

8 Cost estimates and economic implications of expanded RAS testing in metastatic colorectal cancer Full Text The Oncologist, December 9, 2014    Free full text    Clinical Article

9 FOLFIRI and regorafenib combination therapy with dose escalation of irinotecan as fourth-line treatment for patients with metastatic colon cancer according to UGT1A1 genotyping Full Text OncoTargets and Therapy, December 12, 2014    Free full text

10 Effects of preoperative chemoradiotherapy on the likelihood of sphincter preservation surgery in locally advanced distal rectal cancer: a longitudinal study based on pelvic magnetic resonance imaging Annals of Surgical Oncology, December 12, 2014    Clinical Article

11 Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: A Dutch Colorectal Cancer Group (DCCG) randomised phase III trial Annals of Oncology, December 9, 2014    Clinical Article

12 Bacterial 'bunches' linked to some colorectal cancers Johns Hopkins Medicine, December 22, 2014

13 Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy European Journal of Cancer, December 4, 2014    Clinical Article

14 What happens after R1 resection in patients undergoing laparoscopic total mesorectal excision for rectal cancer? A study in 333 consecutive patients Colorectal Disease, December 3, 2014    Clinical Article

15 Adjuvant chemotherapy in rectal cancer: Defining subgroups who may benefit after neoadjuvant chemoradiation and resection A pooled analysis of 3313 patients International Journal of Cancer, December 10, 2014    Clinical Article

16 Liver resection in patients with eight or more colorectal liver metastases British Journal of Surgery, December 18, 2014    Clinical Article

17 Prognosis of stage II and III colon carcinoma treated with adjuvant 5-FU or FOLFIRI in relation to microsatellite status, results of the PETACC-3 trial Annals of Oncology, November 10, 2014    Clinical Article

18 Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX study Full Text BMC Cancer, December 23, 2014    Free full text    Clinical Article

19 Pathologic response of locally advanced rectal cancer to preoperative chemotherapy without pelvic irradiation Colorectal Disease, December 24, 2014    Clinical Article

20 Association between KRAS mutation and lung metastasis in advanced colorectal cancer British Journal of Cancer, December 24, 2014    Clinical Article

Indexed Journals in Oncology: Journal of Clinical Oncology, Cancer Research, Annals Oncologymore

 

The Top Read Articles of 2014 are Now Available

Scouring thousands of peer-reviewed journals and popular press, Our Editors just released the Top Read Articles of the Year. See the Top Read List